RTI-122

RTI-122

Identifiers
IUPAC name (1R,2R)-N-[(2R,3R)-2-amino-3-methoxybutyl]-2-(5-fluoropyridin-2-yl)-N-[4-(4-propan-2-yloxyphenyl)phenyl]cyclopropane-1-carboxamide
CAS Number	3034664-39-3
PubChem CID	167993640
ChemSpider	129307012
ChEMBL	ChEMBL5498825
Chemical and physical data
Formula	C29H34FN3O3
Molar mass	491.607 g·mol−1
3D model (JSmol)	Interactive image
SMILES C[C@H]([C@@H](CN(C1=CC=C(C=C1)C2=CC=C(C=C2)OC(C)C)C(=O)[C@@H]3C[C@H]3C4=NC=C(C=C4)F)N)OC
InChI InChI=1S/C29H34FN3O3/c1-18(2)36-24-12-7-21(8-13-24)20-5-10-23(11-6-20)33(17-27(31)19(3)35-4)29(34)26-15-25(26)28-14-9-22(30)16-32-28/h5-14,16,18-19,25-27H,15,17,31H2,1-4H3/t19-,25-,26-,27-/m1/s1 Key:OXODNABCLPQQDT-CEWWTIOHSA-N

RTI-122 is an experimental drug which acts as a selective agonist for the receptor GPR88, with improved stability and brain penetration compared to older ligands. This receptor is poorly characterised and the development of selective ligands is important for researching its function in the body. In tests on rats, RTI-122 was found to reduce alcohol consumption, suggesting a role for GPR88 in the reward system. ^[1]

References

1. Rahman MT, Decker AM, Ben Hamida S, Perrey DA, Chaminda Lakmal HH, Maitra R, et al. (February 2023). "Improvement of the Metabolic Stability of GPR88 Agonist RTI-13951-33: Design, Synthesis, and Biological Evaluation". Journal of Medicinal Chemistry. 66 (4): 2964–2978. doi:10.1021/acs.jmedchem.2c01983. PMC   9974843 . PMID   36749855.